Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2025)

Top pharmaceutical retailer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical retailer stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best drug store stocks to buy right now are:

Petmed Express (NASDAQ:PETS) is the #1 top pharmaceutical retailer stock out of 6 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Petmed Express (NASDAQ:PETS) is: Value: C, Growth: C, Momentum: D, Sentiment: C, Safety: C, Financials: C, and AI: C.

Petmed Express (NASDAQ:PETS) has a Due Diligence Score of 19, which is -4 points lower than the pharmaceutical retailer industry average of 23.

PETS passed 7 out of 38 due diligence checks and has weak fundamentals. Petmed Express has seen its stock lose -21.79% over the past year, overperforming other pharmaceutical retailer stocks by 7 percentage points.

Petmed Express has an average 1 year price target of $3.20, an upside of 14.29% from Petmed Express's current stock price of $2.80.

Petmed Express stock has a consensus Strong Sell recommendation according to Wall Street analysts. Of the 1 analyst covering Petmed Express, 0% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 100% have issued a Strong Sell.

High Tide (NASDAQ:HITI) is the #2 top pharmaceutical retailer stock out of 6 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for High Tide (NASDAQ:HITI) is: Value: C, Growth: C, Momentum: C, Sentiment: D, Safety: D, Financials: C, and AI: C.

High Tide (NASDAQ:HITI) has a Due Diligence Score of 41, which is 18 points higher than the pharmaceutical retailer industry average of 23.

HITI passed 13 out of 33 due diligence checks and has strong fundamentals. High Tide has seen its stock return 55.91% over the past year, overperforming other pharmaceutical retailer stocks by 85 percentage points.

High Tide has an average 1 year price target of $5.00, an upside of 45.77% from High Tide's current stock price of $3.43.

High Tide stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Wellgistics Health (NASDAQ:WGRX) is the #3 top pharmaceutical retailer stock out of 6 with a Zen Rating of D. Stocks with a rating of D have had an average return of -4.5% per year. Learn more.

The Component Grade breakdown for Wellgistics Health (NASDAQ:WGRX) is: Value: D, Growth: C, Momentum: C, Sentiment: C, Safety: D, Financials: F, and AI: C.

Wellgistics Health (NASDAQ:WGRX) has a Due Diligence Score of 4, which is -19 points lower than the pharmaceutical retailer industry average of 23.

WGRX passed 1 out of 33 due diligence checks and has weak fundamentals.

50% of pharmaceutical retailer stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical retailer stocks to rise by 31.62% over the next year.

0% of pharmaceutical retailer stocks have a Zen Rating of A (Strong Buy), 0% of pharmaceutical retailer stocks are rated B (Buy), 50% are rated C (Hold), 50% are rated D (Sell), and 0% are rated F (Strong Sell).

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical retailer stocks right now are:

Petmed Express (NASDAQ:PETS) is the most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Petmed Express has a valuation score of 14, which is -5 points higher than the pharmaceutical retailer industry average of 19. It passed 1 out of 7 valuation due diligence checks.

Petmed Express's stock has dropped -21.79% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 7 percentage points.

High Tide (NASDAQ:HITI) is the second most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

High Tide has a valuation score of 43, which is 24 points higher than the pharmaceutical retailer industry average of 19. It passed 3 out of 7 valuation due diligence checks.

High Tide's stock has gained 55.91% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 85 percentage points.

Wellgistics Health (NASDAQ:WGRX) is the third most undervalued pharmaceutical retailer stock based on its Valuation Rating of D. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Wellgistics Health has a valuation score of 0, which is -19 points higher than the pharmaceutical retailer industry average of 19. It passed 0 out of 7 valuation due diligence checks.

Pharmaceutical retailer stocks were up 1.44% in the last day, and up 1.03% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are up.